A Much-Needed New Way To Inactivate GPCRs, the Most Common Drug Targets

Coverage, in order

1. 8d ago
   first Harvard Medical School News indie

   A Much-Needed New Way To Inactivate GPCRs, the Most Common Drug Targets

   Lab tests show potential for addressing conditions ranging from high blood pressure to cancer

2. 7d ago
   
   Medical Xpress indie

   A much-needed new way to inactivate GPCRs, the most common drug targets

   About one-third of all drugs approved by the U.S. Food and Drug Administration target G protein-coupled receptors (GPCRs), a family of more than 800 cell-surface receptors that regulate a wide range of vital functions, including blood pressure, heart rate and immunity.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.